chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chest pain late day 3 into day 4; Rapid heart beat late day 3 into day 4; Injection site pain day 1 and 2; Tiredness day 1 and 2; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FF2588) via an unspecified route of administration in the left arm on 05Sep2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included piroxicam (PAXIL) for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 06Sep2021, the patient experienced injection site pain and tiredness on day 1 and 2. On 08Sep2021, the patient experienced chest pain and rapid heartbeat late on day 3 into day 4. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event injection site pain and tiredness was resolved on 07Sep2021, while that of chest pain and rapid heartbeat was unknown at the time of this report.   No follow-up attempts are possible. No further information is expected.
For 3 days I experiencing fever, aches, and dizziness. Then two days later started having Migraines lasted for two weeks straight. Since then getting visual aura and hearing loss.
Child received vaccines on Wednesday (6/29). Mom reports that she noticed redness and swelling at the left deltoid injection site Thursday night (6/30) and into Friday morning. The redness and swelling progressively got worse Friday (7/1) afternoon and mom was contacted by the child's daycare. Friday evening, the left deltoid injection site started feeling "hot" to the touch. On Saturday (7/2) the redness and swelling did not get any worse. Sunday (7/3) mom reported that the swelling and redness had started to subside. Mom reports no medication was administered for symptoms besides daily Zyrtec.
Started getting sick on 10/22/00. Clingy and irritable and thought she was teething. On 10/26/00, she had diarrhea that started with a fever. On 10/27/00 at about 21:00, child started having seizures. Taken to ER and they couldn't start an IV and doctor cut down to ankle. Continued having seizures. Had 1 hour long seizure. Was told that she stopped breathing and was intubated.
chest congestion, chills, fatigue, diarrhea.starting  11/18/21
Fever for 4 days. Body ache for a week.  August 31st, lost feeling in my lower extremities. Numbness and tingling in my legs and feet. Inability to drive due to lack of feeling. Can?t walk anymore. Must use a cane to walk. Continuing to be affected. October 8th 2021, rushed health hospital for stroke symptoms. Determined I had a TIA. ZERO history of strokes or strokes in family .  I have developed tremors in my hands and also right sided weakness in my body. Constant leg pain that prevents me from sleeping. When my legs are not hurting, they are numb pins and needles sensation. When pins and needles sensation are gone, my legs ache and hurt.
3 weeks after the shot a fever of 100-102 when taken under the arm. At one point it was 103 under the arm. Lasted 2 days and then a rash formed all over the body that lasted 3 days. Fussy, lethargic, watery eyes, would not eat.
On 7/18/01 at 04:30, infant was found by mother, not breathing. She had checked on twins at 01:30 and both were fine. Father called 911, while mother initiated CPR. Baby was DOA at ER. Autopsy findings report: proximate cause of death to be sever infectious process of perianal nd perineal area; immediate cause of death atelectasis and pulmonary edema; mechanism of death aspiration asphyxia with pulmonary inadequacy.
From telephone correspondence received at manufacturer on 11/05/2002, pt's mother reported that 2-month-old female infant received ACTHIB (lot #UA720AA), TRIPEDIA (lot #U0549AA), IPOL (lot #U01275) and Prevnar on 09/09/2002. Tylenol was administered right after vaccination. That evening, the pt had a fever of 101.5 F and was extremely agitated and fussy compared to how she normally was. Breastfeeding was difficult and fussiness lasted for approximately 5 days. Mother was not sure if this was reported to VAERS by her doctor.
05/12/2021 Felt sick walking into Cardiologist. Checked blood pressure and it was very high and was prescribed high blood pressure medication. 05/26/2021 Went to see primary care physician changed blood pressure medicine.
Information has been received from  a RN concerning a 6 year old male who on 04/07/2000 was vaccinated in the LA with the first dose of varicella virus vaccine live. On 02/24/2005, the pt experienced a mild breakthrough and at the time of this report was said to be recovering, Additonal information has been requested. This is in follow-up to report (s) previously submitted on 5/16/2005. Information has been received from a registered nurse and a physician concerning a 6-year-old male who on 07-APR-2000 was vaccinated in the left arm with the first dose of VARIVAX (Merck) (lot# 632042/1360J). Concomitant vaccination given on the same day included the first dose of MMR II (lot# 644845/0138N) given in the right arm. On 28-FEB-2005 (previously reported as 24-FEB-2005) the patient developed a mild case of breakthrough varicella and at the time of this report was said to be recovering well. Additional information is not expected.
8 days 9.5 hours after 1st moderna vaccine. emergency room visit for a "thunderclap" headache. diagnosed with a subarachnoid hemorrhage. (brain bleed). no avm, no aneurysm found after 7 days hospitalized with a multitude of scans performed. zero reason for this to have happened?!?!
Patient fainted but regained consciousness within 5 seconds, EMS was immediately called and monitored her symptoms and took her to hospital as she was still reporting light-headedness. Unkown what happened after that.
Muscle aches (especially in back and legs), fever, chills, shaking, dizziness, loss of appetite, fatigue, red swollen injection area. Took TYLENOL for pain. Took shot on Wednesday. Symptoms began that night and resulted in only getting 3 hours of sleep. Thursday symptoms increased and by Friday symptoms were improved except for red swollen arm at the injection site.
Patient received Moderna COVID-19 vaccine and is only 17yrs old.  No adverse events noted.  Clinic spoke with mother of patient and stated that the patient felt better with the Moderna booster than she did when receiving the Pfizer primary series.  Mother was not concerned.
This prospective pregnancy case was reported by a healthcare professional and described the occurrence of vaccine exposure during pregnancy in a 16-year-old female subject who was vaccinated with BOOSTRIX (GlaxoSmithKline), HAVRIX, IPOL, MENACTRA and VARIVAX. The subject's last menstrual period occurred on 25 July 2010. On 18 August 2010 when she was approximately one month pregnant, the subject received a dose of BOOSTRIX (.5 cc, unknown route, right arm), 1st dose of HAVRIX (.5 cc, unknown route and site), 4th dose of IPOL (details unknown), 1st dose of MENACTRA (details unknown), 1st dose of VARIVAX (details unknown), and experienced vaccine exposure during pregnancy. The estimated delivery date was unknown at the time of reporting. Follow-up information was received on 27 September 2010. It was reported that this pregnancy was a normal conception. All vaccinations were given at 0.5 ml via intramuscular route with the exception of VARIVAX which was given subcutaneously. At the time of follow-up, there were no known complications as a result of vaccinations during pregnancy. No problems have been indicated by the subject and she continues to be followed by her obstetrician. The reporting nurse considered these exposures to be serious.
Patient was given 1 dose of flu vaccine in clinic on 9/20/22. Patient's mom had signed patient up to receive a flu vaccine through the school. Paper was not pulled from school stack and patient was given an additional dose of flu vaccine at school on 10/28/22. Mother notified, reports patient is having no adverse symptoms or reactions.
Having a cold; A spontaneous report was received from a consumer concerning herself, a 83-year-old patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced cold.  The patient's medical history included high blood pressure. Concomitant medications reported included carvedilol for high blood pressure, iron, amlodipine, levothyroxine, aspirin, famotidine, losartan, metformin, biosil, multivitamin with minerals, calcium carbonate, vitamin D and magnesium.  On 18 Jan 2021, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 (Batch number: 038K20A) via unknown route for prophylaxis of COVID-19 infection.   On an unknown date the patient was having a cold.  Treatment information was not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of the event was unknown.
From telephone correspondence received at AP on 08/28/2002, it was reported that a 57 year old patient received TD ADS ADULT (Lot # U0528AA, Exp Date 04/2004) in the right deltoid on 08/19/2002.  On 08/22/2002, the patient developed swelling at the site, swelling, redness and heat from shoulder to wrist with low-grade fever.  The physician recommended cold to area and Tylenol.  It is not reported whether the patient recovered from these adverse events.  See report U2002-00683 with the same reporter.
Vaccine Administration Error - administered vaccine underage.  No adverse effects were noted following 15 minutes wait period.
His mom called us this morning. She informed us that he got a bump under his left arm pit  couple of hours after receiving vaccine. I advised her to call his Dr.  I checked with mom this evening. He is doing well. He is under obervation.
No adverse event; A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022; A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022; This spontaneous case was reported by a nurse and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022), COVID-19 IMMUNISATION (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) in a 2-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. AS1412B) for COVID-19 prophylaxis.    Co-suspect product included non-company product TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) for COVID-19 vaccination.    No Medical History information was reported.   On 15-Jul-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2022, the patient received first dose of TOZINAMERAN (PFIZER BIONTECH COVID-19 VACCINE) (unknown route) 1 dosage form. On 10-Aug-2022, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022) and COVID-19 IMMUNISATION (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022), COVID-19 IMMUNISATION (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for INTERCHANGE OF VACCINE PRODUCTS (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022) and COVID-19 IMMUNISATION (A child received the 1st dose of Moderna Covid-19 on 15-Jul-2022 and received the 2nd dose of Pfizer Covid-19 vaccine on 10-Aug-2022).    No concomitant medications was reported. Patient administered 2nd dose of Pfizer with lot number FT9142 on 10-Aug-2022. No treatment medications was reported.
left deltoid sore; This case was reported by a consumer via other manufacturer and described the occurrence of muscle soreness in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis and COVID 19 VACCINE PFIZER (batch number BNT162B2, expiry date unknown) for prophylaxis.   On an unknown date, the patient received Shingrix, Influenza vaccine Quadrivalent unspecified season and COVID 19 VACCINE PFIZER. On an unknown date, less than a year after receiving Shingrix and Influenza vaccine Quadrivalent unspecified season, the patient experienced muscle soreness. On an unknown date, the outcome of the muscle soreness was unknown.   It was unknown if the reporter considered the muscle soreness to be related to Shingrix and Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. Shingrix was the breeze. Been 2021 pincushion 3 vaccine of Pfizer Covid vaccine, Flu shot and now this Shingrix. But the patient left deltoid was sore .
Metabolic encephalopathy (felt under the weather,seizure, coma, double vision, fever, headache); This spontaneous report as received from a physician via a company representative refers to a 36 or 37 years old female patient. The patient's historical vaccine included unspecified Covid-19 vaccine. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided.  On an unknown date, the patient was vaccinated with first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) (exact dose, route of administration, anatomical location, lot # and expiration date were not reported) for prophylaxis         On an unknown date, 2 days after vaccination, the patient developed fever and headache. The patient was told to take ibuprofen or paracetamol (TYLENOL). The patient then felt "under the weather" and developed double vision so she went to an emergency room (ER). In the ER, she had seizures and went into a coma so she was admitted to the hospital. She was intubated to protect her airway. In the hospital, she was diagnosed with metabolic encephalopathy. The patient was discharged from the unspecified hospital about 2 weeks ago and she has been in a rehab. She could not work so she was just sitting at home.   The outcome of metabolic encephalopathy was unknown. Causality assessment was not provided.  Upon internal review, the event of metabolic encephalopathy was determined to be medically significant, disabling and life threatening.
My heartbeat has been rapid at times. I can feel it in my chest beating heavy at times. It's not all the time, but it hasn't gone away.  I thought it was caffeine or sugar, so I cut them out of my diet, but it is still happening. I'm going for my physical on 4/29, so I was going to get it checked out then.
This spontaneous report as received from a pharmacist refers to a female patient of unknown age. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, an empty carton single dose ZOSTAVAX (lot # K007177,  parenteral, expiration date 21-AUG-2014), for shingles, caused an anonymous patient to miss a dose. No adverse effects reported. No concomitant therapies were reported. The outcome of the events was unknown. Additional information has been requested.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 71-year-old male patient received BNT162b2 (BNT162B2), on 20Feb2021 as dose 1, single (Batch/Lot number: unknown), in left arm, on 13Mar2021 as dose 2, single (Batch/Lot number: unknown), in left arm and on 05Oct2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 70 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "Sleep apnea" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing), notes: High blood pressure; "Overweight" (unspecified if ongoing); "Known allergies:Some antibiotics and pain killers" (unspecified if ongoing), notes: Known allergies: Some antibiotics and pain killers. The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset May2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, suspected covid-19. Adverse event: First I want to say it stopped the progress of COVID within 24 hours and I felt much better in just a few days. The adverse effect is a horrible bitter taste in my mouth 24/7 while taking the medication. I would wake up every 2 hours at night with extremely dry mouth and the bitter taste. I took my last dose this morning and at 2:30 I still have the taste. I just finished the course of doses so hopefully tomorrow I will have some relief.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
died just 10 days after being given the vaccine/ put sepsis on her medical records; This is a spontaneous report from a contactable consumer report for Aunt. A 59-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) via an unspecified route of administration in Jan2021 at single dose for COVID-19 immunization. Medical history included schizophrenia and depression. The patient's concomitant medications were not reported. Consumer's aunt (patient) was housed in a facility. She was being treated for schizophrenia and depression. This was one of the facilities that chose to house Covid patients during the pandemic. Many of the patients here contracted covid19 during this time and they had to do a full facility lockdown and quarantine. The patient tested positive in Nov2020 and was quarantined to her room for 10 days. 3 weeks ago (in Jan2021), she received the Pfizer vaccine. Consumer's family was not given notice of this and we are sad to report that she died just 10 days after being given the vaccine. They put sepsis on her medical records and have not connected this to the vaccine. Consumer stated aunt was just 59 yrs old, though she was being treated for her mental illness, she was physically healthy. Consumer's family gravely concerned that this facility neglected her health by administering the vaccine without considering possible reactions from the medication she was taking, or the fact she had Covid just months prior. Patient died on an unspecified date. it was unknown if an autopsy performed.  Information on Lot/Batch number has been requested.; Reported Cause(s) of Death: died just 10 days after being given the vaccine/ put sepsis on her medical records
No adverse affects reported; expired dose of PNEUMOVAX 23 was administered; This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. The patient's medical history, concurrent conditions, concomitant medications and drug reactions/ allergies were not reported.  On 14-MAR-2019, the patient was vaccinated with an expired dose of pneumococcal vaccine, polyvalent (23-valent) (PNEUMOVAX23) with lot # N020501, expiry date: 03-MAR-2019 intramuscularly for prophylaxis (dosing details not reported). No adverse effects reported. No product quality complaint (PQC) identified.
On 2/23/21, about 12 days after the vaccine was received, I felt chest pains in the late afternoon.  At midnight, I woke up with uncontrollable chills and shakes, with a low-grade fever that hovered in the 99.5 -100  range.    I attempted to get up and struggled to breathe,; it was as if my abdominal and lower back muscles were seizing.  I had to crawl to a kneeling position to urinate.  I took several Tylenol then went back to lie down; after a few hours, the fever subsided, and I was able to briefly fall back asleep.  At 4:00 a.m. the fever and major chills subsided, with no fevers reported since then, and only occasional chills.  However, the muscle fatigue, pain and stiffness have become frighteningly debilitating.  On Wednesday - Friday, the three days after I first experienced symptoms, each day it took me between 1.5 - 2 hours  to get out of bed and finally get to a standing position.    During the day on each day following my first symptoms, I have been able to gradually walk around, go up and down stairs, use the bathroom, and perform basic tasks.    However, when the evening comes, it is a different story.  12 midnight - 10 a.m. are the worst hours, as any extended period lying down results in my muscles seizing, freezing and stiffening up.  After falling asleep for an hour, it takes 10-20 minutes to mobilize enough (using a crutch and assistance) to get to the bathroom.  After falling asleep for 2-3 hours, it takes 30-40 minutes to do the same.  And, if I fall asleep for 3+ hours (which is about as long as I've been able to sleep since the adverse reactions began), it will take 1.5 - 2 hours to get completely mobile.  This is when I finally wake for the day, and it takes about 10 minutes to raise my head and turn my torso, then another 10-15 minutes to get my legs off the bed and assume a crouching position, then 30-60 minutes to stand on my own.
This spontaneous report as received from a nurse via company representative, refers to a 12 year old male patient. On 30-MAR-2015, the patient was vaccinated with his second dose of GARDASIL 0.5 ml intramuscularly in the left arm (lot # K008931, expiration date: 04-MAR-2017). On an unspecified date in 2015, the patient developed widespread rash, hives and blisters. The symptoms resolved on 02-APR-2015 without requiring medical treatment. The patient sought medical attention - phone call was placed to the office by patient's mother. The nurse also stated, that the patient developed a similar reaction while taking penicillin on an unspecified date in the past. The relatedness between the events and GARDASIL was not provided. Additional information has been requested.
On the evening after her second dose she experienced disorientation, vomiting, incontinence, confusion.  Symptoms persisted for days and she lay prostrate in bed.  Comes to the office 6 days later, oriented x 5 but 24/30(prior mini-cog 4/5), mild elevation of LFTs and platelet clumping.
Patient became unsteady on his feet when he was getting up to be discharged home, patient with near syncopal episode. Patient was instructed to sit down. The Nurse Practitioner and Fire Rescue at patients side. Patients legs were elevated, patient was provided water to drink. Paramedics obtained vitals and patients BP ranged from 207/119- 175/114. Patient did not have prescribed medications at home for Hypertensive crisis and it was determined that it was best for the patient to receive higher level of care for stabilization.  Fire rescue was called, patient was evaluated and the decision was made to transport to ER.